Logo image of SHO

SUNSTONE HOTEL INVESTORS INC (SHO) Stock Fundamental Analysis

USA - NYSE:SHO - US8678921011 - REIT

9.23 USD
+0.15 (+1.65%)
Last: 10/15/2025, 11:31:47 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SHO. SHO was compared to 129 industry peers in the Diversified REITs industry. The financial health of SHO is average, but there are quite some concerns on its profitability. SHO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SHO was profitable.
In the past year SHO had a positive cash flow from operations.
Of the past 5 years SHO 4 years were profitable.
Of the past 5 years SHO 4 years had a positive operating cash flow.
SHO Yearly Net Income VS EBIT VS OCF VS FCFSHO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

SHO has a Return On Assets (0.14%) which is comparable to the rest of the industry.
SHO has a Return On Equity (0.21%) which is in line with its industry peers.
SHO has a worse Return On Invested Capital (2.00%) than 64.34% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SHO is in line with the industry average of 3.01%.
Industry RankSector Rank
ROA 0.14%
ROE 0.21%
ROIC 2%
ROA(3y)3.11%
ROA(5y)-0.84%
ROE(3y)4.55%
ROE(5y)-1.22%
ROIC(3y)2.7%
ROIC(5y)N/A
SHO Yearly ROA, ROE, ROICSHO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

SHO has a Profit Margin of 0.44%. This is comparable to the rest of the industry: SHO outperforms 44.19% of its industry peers.
In the last couple of years the Profit Margin of SHO has declined.
SHO has a Operating Margin of 7.77%. This is amonst the worse of the industry: SHO underperforms 80.62% of its industry peers.
In the last couple of years the Operating Margin of SHO has declined.
Looking at the Gross Margin, with a value of 60.49%, SHO is doing worse than 65.89% of the companies in the same industry.
SHO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.77%
PM (TTM) 0.44%
GM 60.49%
OM growth 3YN/A
OM growth 5Y-9.81%
PM growth 3Y4.77%
PM growth 5Y-22.47%
GM growth 3Y-0.55%
GM growth 5Y-0.8%
SHO Yearly Profit, Operating, Gross MarginsSHO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SHO is destroying value.
The number of shares outstanding for SHO has been reduced compared to 1 year ago.
SHO has less shares outstanding than it did 5 years ago.
SHO has a worse debt/assets ratio than last year.
SHO Yearly Shares OutstandingSHO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
SHO Yearly Total Debt VS Total AssetsSHO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.13, we must say that SHO is in the distress zone and has some risk of bankruptcy.
With an excellent Altman-Z score value of 1.13, SHO belongs to the best of the industry, outperforming 80.62% of the companies in the same industry.
SHO has a debt to FCF ratio of 5.18. This is a neutral value as SHO would need 5.18 years to pay back of all of its debts.
SHO has a better Debt to FCF ratio (5.18) than 98.45% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that SHO is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.44, SHO belongs to the best of the industry, outperforming 91.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 5.18
Altman-Z 1.13
ROIC/WACC0.27
WACC7.38%
SHO Yearly LT Debt VS Equity VS FCFSHO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 1.30 indicates that SHO should not have too much problems paying its short term obligations.
SHO has a Current ratio of 1.30. This is comparable to the rest of the industry: SHO outperforms 58.14% of its industry peers.
SHO has a Quick Ratio of 1.30. This is a normal value and indicates that SHO is financially healthy and should not expect problems in meeting its short term obligations.
SHO has a Quick ratio (1.30) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.3
SHO Yearly Current Assets VS Current LiabilitesSHO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

SHO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -90.91%.
Measured over the past years, SHO shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -23.38% on average per year.
Looking at the last year, SHO shows a small growth in Revenue. The Revenue has grown by 0.37% in the last year.
The Revenue has been decreasing by -4.07% on average over the past years.
EPS 1Y (TTM)-90.91%
EPS 3Y29.76%
EPS 5Y-23.38%
EPS Q2Q%-72.73%
Revenue 1Y (TTM)0.37%
Revenue growth 3Y21.17%
Revenue growth 5Y-4.07%
Sales Q2Q%4.97%

3.2 Future

The Earnings Per Share is expected to grow by 13.00% on average over the next years. This is quite good.
SHO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.44% yearly.
EPS Next Y-90.98%
EPS Next 2Y-7.93%
EPS Next 3Y13%
EPS Next 5YN/A
Revenue Next Year5.1%
Revenue Next 2Y5.43%
Revenue Next 3Y4.44%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SHO Yearly Revenue VS EstimatesSHO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SHO Yearly EPS VS EstimatesSHO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2

3

4. Valuation

4.1 Price/Earnings Ratio

SHO is valuated quite expensively with a Price/Earnings ratio of 461.50.
SHO's Price/Earnings ratio is a bit more expensive when compared to the industry. SHO is more expensive than 61.24% of the companies in the same industry.
When comparing the Price/Earnings ratio of SHO to the average of the S&P500 Index (27.49), we can say SHO is valued expensively.
A Price/Forward Earnings ratio of 77.78 indicates a quite expensive valuation of SHO.
SHO's Price/Forward Earnings ratio is in line with the industry average.
SHO is valuated expensively when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 461.5
Fwd PE 77.78
SHO Price Earnings VS Forward Price EarningsSHO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

71.32% of the companies in the same industry are more expensive than SHO, based on the Enterprise Value to EBITDA ratio.
89.15% of the companies in the same industry are more expensive than SHO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.45
EV/EBITDA 12.39
SHO Per share dataSHO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as SHO's earnings are expected to grow with 13.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.93%
EPS Next 3Y13%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.00%, SHO has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 7.01, SHO is paying slightly less dividend.
SHO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 4%

5.2 History

The dividend of SHO decreases each year by -9.74%.
SHO has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of SHO decreased in the last 3 years.
Dividend Growth(5Y)-9.74%
Div Incr Years2
Div Non Decr Years2
SHO Yearly Dividends per shareSHO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.5 1

5.3 Sustainability

2126.95% of the earnings are spent on dividend by SHO. This is not a sustainable payout ratio.
DP2126.95%
EPS Next 2Y-7.93%
EPS Next 3Y13%
SHO Yearly Income VS Free CF VS DividendSHO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M
SHO Dividend Payout.SHO Dividend Payout, showing the Payout Ratio.SHO Dividend Payout.PayoutRetained Earnings

SUNSTONE HOTEL INVESTORS INC

NYSE:SHO (10/15/2025, 11:31:47 AM)

9.23

+0.15 (+1.65%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-07 2025-11-07/bmo
Inst Owners101.99%
Inst Owner Change-0.01%
Ins Owners1.26%
Ins Owner Change1.7%
Market Cap1.75B
Analysts73.33
Price Target9.74 (5.53%)
Short Float %7.4%
Short Ratio5.74
Dividend
Industry RankSector Rank
Dividend Yield 4%
Yearly Dividend0.45
Dividend Growth(5Y)-9.74%
DP2126.95%
Div Incr Years2
Div Non Decr Years2
Ex-Date09-30 2025-09-30 (0.09)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)49.22%
Min EPS beat(2)-65.59%
Max EPS beat(2)164.03%
EPS beat(4)2
Avg EPS beat(4)6.67%
Min EPS beat(4)-100%
Max EPS beat(4)164.03%
EPS beat(8)6
Avg EPS beat(8)345.59%
EPS beat(12)10
Avg EPS beat(12)313.01%
EPS beat(16)13
Avg EPS beat(16)247%
Revenue beat(2)0
Avg Revenue beat(2)-1.93%
Min Revenue beat(2)-3.82%
Max Revenue beat(2)-0.05%
Revenue beat(4)1
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-3.82%
Max Revenue beat(4)0.7%
Revenue beat(8)4
Avg Revenue beat(8)-0.69%
Revenue beat(12)7
Avg Revenue beat(12)0.76%
Revenue beat(16)10
Avg Revenue beat(16)1.95%
PT rev (1m)-0.94%
PT rev (3m)-3.09%
EPS NQ rev (1m)-166.7%
EPS NQ rev (3m)-259.99%
EPS NY rev (1m)-70.59%
EPS NY rev (3m)-90.85%
Revenue NQ rev (1m)-1.72%
Revenue NQ rev (3m)-4.42%
Revenue NY rev (1m)-0.79%
Revenue NY rev (3m)-1.75%
Valuation
Industry RankSector Rank
PE 461.5
Fwd PE 77.78
P/S 1.88
P/FCF 10.45
P/OCF 10.45
P/B 0.89
P/tB 0.89
EV/EBITDA 12.39
EPS(TTM)0.02
EY0.22%
EPS(NY)0.12
Fwd EY1.29%
FCF(TTM)0.88
FCFY9.57%
OCF(TTM)0.88
OCFY9.57%
SpS4.92
BVpS10.42
TBVpS10.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.14%
ROE 0.21%
ROCE 2.54%
ROIC 2%
ROICexc 2.06%
ROICexgc 2.06%
OM 7.77%
PM (TTM) 0.44%
GM 60.49%
FCFM 17.95%
ROA(3y)3.11%
ROA(5y)-0.84%
ROE(3y)4.55%
ROE(5y)-1.22%
ROIC(3y)2.7%
ROIC(5y)N/A
ROICexc(3y)2.94%
ROICexc(5y)N/A
ROICexgc(3y)2.94%
ROICexgc(5y)N/A
ROCE(3y)3.42%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-13.98%
ROICexc growth 3YN/A
ROICexc growth 5Y-13.98%
OM growth 3YN/A
OM growth 5Y-9.81%
PM growth 3Y4.77%
PM growth 5Y-22.47%
GM growth 3Y-0.55%
GM growth 5Y-0.8%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 5.18
Debt/EBITDA 4.27
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 1.57
Cash Conversion 82.51%
Profit Quality 4053.66%
Current Ratio 1.3
Quick Ratio 1.3
Altman-Z 1.13
F-Score5
WACC7.38%
ROIC/WACC0.27
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-90.91%
EPS 3Y29.76%
EPS 5Y-23.38%
EPS Q2Q%-72.73%
EPS Next Y-90.98%
EPS Next 2Y-7.93%
EPS Next 3Y13%
EPS Next 5YN/A
Revenue 1Y (TTM)0.37%
Revenue growth 3Y21.17%
Revenue growth 5Y-4.07%
Sales Q2Q%4.97%
Revenue Next Year5.1%
Revenue Next 2Y5.43%
Revenue Next 3Y4.44%
Revenue Next 5YN/A
EBIT growth 1Y-25.98%
EBIT growth 3YN/A
EBIT growth 5Y-13.48%
EBIT Next Year193.94%
EBIT Next 3Y48.3%
EBIT Next 5YN/A
FCF growth 1Y-25.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.63%
OCF growth 3Y81.77%
OCF growth 5Y-10.15%